New incident report
Incident Report Number: 2020-2266
Registrant Reference Number: 2019-CA-000067
Registrant Name (Full Legal Name no abbreviations): The Hartz Mountain Corporation
Address: 400 Plaza Drive
City: Secaucus
Prov / State: New Jersey
Country: USA
Postal Code: 07094-3688
Domestic Animal
Country: CANADA
Prov / State: UNKNOWN
PMRA Registration No. 29721 PMRA Submission No. EPA Registration No.
Product Name: UltraGuard Plus Reflective Flea and Tick Collar for Cats and Kittens
Yes
Unknown
Site: Animal / Usage sur un animal domestique
Animal's Owner
Cat / Chat
Domestic Longhair
1
Female
4
12.2
lbs
Skin
>24 hrs <=3 days / >24 h <=3 jours
<=30 min / <=30 min
System
Unknown / Inconnu
No
No
Unknown/Inconnu
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On 01-Aug-2019, a 4 year old, 12.2 pound, neutered, female, Domestic Longhair cat, in unknown condition, with concomitant medical condition of fleas, was administered 1 collar of UltraGuard Plus Reflective Flea and Tick Collar for Cats and Kittens (Tetrachlorvinphos / S Methoprene) via the topical route by the animal owner. Upon product application, the cat exhibited skittish behavior for a duration of approximately 30 seconds. On 02-Aug-2019, the cat developed lethargy, anorexia and adipsia. On 03-Aug-2019, the animal owner consulted with an unspecified poison control company and the product was removed per their recommendations. At an unspecified time post product removal, the clinical sign of anorexia, resolved. The cat had not been evaluated by a veterinarian, no treatment had been performed and the clinical signs continued at the time of the call. Veterinary evaluation was recommended if the clinical signs persisted or worsened. No further information was received in this case.
Minor
The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and can not form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.